In his clinical practice, mostly within HIV/AIDS, Diego has seen the need for big improvements in care. He’s now running Janssen Healthcare Innovation, a newly created business within Johnson & Johnson, aiming to help reinvent care delivery. We’ve been really impressed with his ideas about how a pharma company can support big changes across the system.

As Mobile Health Manager at Janssen Healthcare Innovation, a newly created business within Johnson & Johnson, Fran aims to help reinvent care delivery. We’ve been really impressed with his ideas about how a pharma company can support big changes across the system and he shared his thoughts with us at Health 2.0. 

In this session, speakers demoed a diverse set of solutions aimed at improving quality of care in the clinical setting. From best practice sharing to population health to provider-to-provider communication tools, these solutions streamline processes and improve quality and patient safety.

Matthew sat down with health care delivery leaders to discuss how new technology platforms, payors, and providers are working together for enhance patient care delivery and engagement.

At Janssen they believe Digital Health technologies will play a fundamental enabling role in the transformation of healthcare around the world. To that end they are building new digitally enabled businesses related to Janssen’s core therapeutic areas and also supporting the larger Digital Health community through a number of activities including this year’s Digital Health Masterclass. In this session they share some examples of these activities and our experiences along the way.

Dive into the Innovation Think Tank, an interactive session of brainstorming with the Janssen Healthcare Innovation team on how to drive integrated care businesses and enabling technologies forward in our changing healthcare landscape. A panel discussion hosted by JHI team members introduced how its new business models are providing Care4Today™ in the cardiac rehabilitation, mental health, orthopaedic care and medication adherence spaces. This was followed up by a dynamic session where breakout groups will brainstorm opportunities to expand and improve these business models, as well as identify ways to address innovation key challenges. A ‘where is the future of innovation?’ brainstorm group was hosted by Diego Miralles, M.D., Janssen’s Global Head of Innovation. One especially innovative person from each group presented their solution to the audience.